Colfax Corporation

NYSE: CFX · Real-Time Price · USD
39.06
-1.53 (-3.77%)
At close: Apr 05, 2022, 6:00 AM

Company Description

Colfax Corporation operates as a diversified technology company worldwide.

The company operates in two segments, Fabrication Technology and Medical Technology.

The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding, as well as gas control equipment.

It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips.

This segment sells its products through independent distributors and direct sales to the general industry, construction, infrastructure, transportation, energy, renewable energy, and medical and life sciences markets principally under the ESAB brand.

The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries.

It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger.

This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand.

Colfax Corporation was founded in 1860 and is headquartered in Wilmington, Delaware.

Colfax Corporation
Colfax Corporation logo
Country United States
IPO Date May 8, 2008
Industry Industrial - Machinery
Sector Industrials
Employees 16,200
CEO Matthew Trerotola

Contact Details

Address:
420 National Business Pkwy Fl 5
Annapolis Junction, Maryland
United States
Website https://www.colfaxcorp.com

Stock Details

Ticker Symbol CFX
Exchange NYSE
Fiscal Year n/a
Reporting Currency USD
CIK Code 0001420800
CUSIP Number 194014106
ISIN Number US1940141062
Employer ID 54-1887631
SIC Code 3842

Key Executives

No executives data available.

Latest SEC Filings

Date Type Title
Jul 01, 2025 4 Filing
Jun 26, 2025 11-K Filing
Jun 03, 2025 4 Filing
May 30, 2025 SD Filing
May 23, 2025 4 Filing
May 23, 2025 4 Filing
May 23, 2025 4 Filing
May 23, 2025 4 Filing
May 23, 2025 4 Filing
May 23, 2025 4 Filing